7Baggers

Quantum-Si Incorporated
(NASDAQ:QSI) 

QSI stock logo

Quantum-Si incorporated operates first next-generation protein sequencing and genomics platform for healthcare industries. It offers a single molecule detection solution to decode the molecules of life, including sample preparation, single molecule, massively parallel, and protein identification. Th...

Founded: 2013
CEO: John Stark  
Sector: Healthcare
Industry: Biotechnology
HealthcareSPAC
Share this website to your friends
• Market Cap:
• Exchange:
• Shs Outstanding:
• Employees:
• Beta:
• Return on Equity (ROE) ttm:
• Return on Assets (ROA) ttm:
• EPS ttm:
• Book value per Share:
• Cash per Share:
• Current ast per Share:
• P/E ttm:
• P/E forward:
• P/E ttm high:
• P/E ttm low:
• P/S ttm:
• P/B ttm:
• P/FCF ttm:
• PEG ratio:
• Cash Ratio ttm:
• Quick Ratio ttm:
• Current Ratio ttm:
• Gross Mgn ttm:
• EBITDA Mgn ttm:
• Operating Mgn ttm:
• Net Income Mgn ttm:
• Trailing Div yield:
• Forward Div yield:
• Payout Ratio ttm:
• Ex-Dividend date:
• Target Price High:
• Target Price Low:
• Target Price Mean:
• Number of Analysts:
• Debt Ratio ttm:
• Debt to Equity ttm:
• Total Net Debt:
At a glance:
Bull Thesis:
Bear Thesis:
Main Competitors:
Moat:
Income Statements:
Quarterly
Annual
    Unit: USD2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2020-09-30 
                         
      revenue
    		                     
      yoy
    		                     
      qoq
    		                     
      product
    		216,000 415,000 505,000 558,000 808,000 1,149,000 764,000 584,000 428,000 377,000 216,000 187,000 251,000         
      service
    		42,000 36,000 47,000 33,000 34,000 43,000 23,000 38,000 29,000 23,000 7,000 18,000 3,000         
      total revenue
    		258,000 451,000 552,000 591,000 842,000 1,192,000 787,000 622,000 457,000 400,000 223,000 205,000 254,000         
      cost of revenue
    		     582,000 420,000 268,000 188,000 222,000 115,000 127,000 130,000         
      total cost of revenue
    		184,000 329,000 358,000 240,000 356,000                 
      gross profit
    		74,000 122,000 194,000 351,000 486,000 610,000 367,000 354,000 269,000 178,000 108,000 78,000 124,000         
      yoy
    		-84.77% -80.00% -47.14% -0.85% 80.67% 242.70% 239.81% 353.85% 116.94%             
      qoq
    		-39.34% -37.11% -44.73% -27.78% -20.33% 66.21% 3.67% 31.60% 51.12% 64.81% 38.46% -37.10%          
      gross margin %
    		Infinity% Infinity% Infinity% Infinity% Infinity% Infinity% Infinity% Infinity% Infinity% Infinity% Infinity% Infinity% Infinity% NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN% 
      operating expenses:
    		                     
      research and development
    		14,487,000 10,946,000 13,883,000 15,213,000 13,717,000 16,988,000 16,171,000 14,381,000 12,101,000 16,437,000 16,587,000 15,834,000 18,167,000 18,157,000 16,675,000 18,459,000 18,771,000 14,385,000 11,104,000 13,114,000  
      selling, general and administrative
    		9,640,000 10,270,000 10,707,000 11,896,000 11,881,000 14,299,000 12,284,000 12,424,000 11,528,000 11,624,000 10,696,000 11,136,000 11,178,000 11,203,000 10,983,000 11,741,000 8,369,000     
      total operating expenses
    		24,127,000 21,216,000 39,967,000 30,471,000 25,598,000 31,287,000 28,455,000 26,805,000 23,629,000 28,061,000 27,283,000 26,970,000 29,345,000 38,843,000 27,658,000 30,200,000 27,140,000 27,790,000 25,175,000 32,164,000  
      income from operations
    		-24,053,000 -21,094,000 -39,773,000 -30,120,000 -25,112,000 -30,677,000 -28,088,000 -26,451,000 -23,360,000 -27,883,000 -27,175,000 -26,892,000 -29,221,000 -38,843,000 -27,658,000 -30,200,000 -27,140,000 -27,790,000 -25,175,000 -32,164,000 -50,637 
      yoy
    		-4.22% -31.24% 41.60% 13.87% 7.50% 10.02% 3.36% -1.64% -20.06% -28.22% -1.75% -10.95% 7.67% 39.77% 9.86% -6.11% 53497.17%     
      qoq
    		14.03% -46.96% 32.05% 19.94% -18.14% 9.22% 6.19% 13.23% -16.22% 2.61% 1.05% -7.97% -24.77% 40.44% -8.42% 11.27% -2.34% 10.39% -21.73% 63418.77%  
      operating margin %
    		-Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% 
      dividend income
    		131,000         2,262,000 2,572,000 2,483,000 2,219,000 2,013,000 1,381,000 1,052,000 855,000 1,808,000 739,000   
      interest income
    		1,744,000                   2,000  
      change in fair value of warrant liabilities
    		357,000 279,000 1,516,000 -994,000 3,401,000 -4,639,000 121,000 477,000 319,000 -197,000 -162,000 -310,000 391,000 1,122,000 137,000 2,337,000 2,647,000 937,000 6,975,000 -3,533,000  
      other income
    		28,000 990,000 -7,000   -9,000 9,000 -12,000 -7,000 -4,000 -15,000 -854,000 3,000,000   -5,603,000    3,000  
      income before provision for income taxes
    		-21,793,000 -17,603,000 -35,684,000 -28,816,000 -19,178,000 -33,108,000 -25,270,000 -23,099,000 -19,474,000 -22,048,000 -24,728,000 -25,573,000 -23,611,000 -33,140,000 -31,713,000 -32,414,000 -35,175,000 -29,422,000 -18,091,000 -35,697,000  
      benefit for income taxes
    		122,000                     
      net income
    		-21,671,000 -17,611,000 -35,703,000 -28,836,000 -19,189,000 -33,121,000 -25,313,000 -23,099,000 -19,474,000            -50,253 
      yoy
    		12.93% -46.83% 41.05% 24.84% -1.46%                 
      qoq
    		23.05% -50.67% 23.81% 50.27% -42.06% 30.85% 9.58% 18.61%              
      net income margin %
    		-Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN% -Infinity% 
      net loss per common share attributable to common stockholders, basic and diluted
    		-100 -70 -170 -160 -110 -230 -180 -160 -140 -160 -170 -180 -170 -240 -230 -230 -250 -100 -130 -3,050  
      weighted-average shares used for eps calculation
    		216,472,000 197,765,000 209,041,000 183,625,000 182,303,000 143,196,000 142,399,000 141,939,000 141,773,000 141,300,000 141,660,018,000 141,506,818,000 140,280,332,000 139,255,131,000 139,542,660,000 139,000,261,000 138,619,929,000 79,578,540,000 136,456,848,000 11,696,084,000  
      other comprehensive income
    		                     
      net unrealized loss on marketable securities, net of tax
    		-304,000    -53,000    -28,000             
      foreign currency translation adjustment
    		-72,000 -2,000 -8,000 16,000 6,000 -15,000 -3,000 -2,000 -5,000             
      total other comprehensive loss, net of tax
    		-376,000    -47,000    -33,000             
      comprehensive loss
    		-22,047,000 -17,671,000 -35,609,000 -28,874,000 -19,236,000 -33,229,000 -25,153,000 -23,073,000 -19,507,000             
      lease termination expense
    		  13,577,000                   
      legal settlement expense, net of insurance proceeds
    		  1,800,000 3,362,000                  
      dividend and interest income
    		 1,859,750 2,580,000 2,312,000 2,547,000 2,217,000 2,688,000 2,887,000 3,574,000             
      provision for income taxes
    		 -8,000 -19,000 -20,000 -11,000 -13,000 -43,000               
      net unrealized gain on marketable securities, net of tax
    		 -58,000 102,000 -54,000  -93,000 163,000 28,000              
      total other comprehensive income, net of tax
    		 2,250 94,000                   
      revenue:
    		                     
      cost of revenue:
    		                     
      other expense
    		   -14,000 -14,000            -11,537,000     
      other comprehensive income:
    		                     
      total other comprehensive gain, net of tax
    		   -38,000  -108,000 160,000 26,000              
      unrealized gain on trading securities
    		                     
      realized loss on trading securities
    		                     
      other comprehensive gain:
    		                     
      gain on marketable securities
    		                     
      other comprehensive loss:
    		                     
      unrealized gain on marketable securities
    		         2,075,500 1,953,000           
      realized loss on marketable securities
    		         -1,622,250 -1,901,000           
      net loss and comprehensive loss
    		         -22,048,000 -24,728,000 -25,573,000 -23,611,000 -33,140,000 -31,713,000 -32,414,000 -35,175,000 -29,422,000 -18,091,000 -35,697,000  
      interest expense
    		                   -5,000  
      other (expense)
    		             2,568,000 -5,573,000   -156,750 -630,000   
      general and administrative
    		                 12,166,000 12,989,000 17,805,000  
      sales and marketing
    		                 1,239,000 1,082,000 1,245,000  
      formation and general and administrative expenses
    		                    50,637 
      other income:
    		                     
      interest earned on cash and cash equivalents held in trust account
    		                    384 
      weighted-average shares outstanding of class a redeemable common stock
    		                    11,500,000 
      basic and diluted income per share, class a redeemable common stock
    		                     
      weighted-average shares outstanding of class a and class b non-redeemable common stock
    		                    3,280,000 
      basic and diluted net loss per share, class a and class b non-redeemable common stock
    		                    -0.02 
    Balance Sheets:
    Quarterly
    Annual
      Unit: USD2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 
                           
        assets
      		                     
        current assets:
      		                     
        cash and cash equivalents
      		36,200,000 21,639,000 30,910,000 22,188,000 37,293,000 49,241,000 42,268,000 59,552,000 53,163,000 133,860,000 93,822,000 87,934,000 81,660,000 84,319,000 78,263,000 81,272,000 34,984,000 35,785,000 62,103,000 521,936,000  
        marketable securities, current
      		91,138,000 141,271,000 194,934,000                   
        accounts receivable
      		203,000 561,000 755,000 917,000 1,032,000 1,333,000 1,022,000 598,000 242,000 368,000 466,000 327,000 82,000         
        legal settlement insurance receivable
      		 4,638,000 4,638,000 4,638,000                  
        inventory
      		2,191,000 3,197,000 3,513,000 3,903,000 4,423,000 4,067,000 4,091,000 4,854,000 4,946,000 3,945,000 2,325,000 1,978,000 1,708,000         
        prepaid expenses and other current assets
      		5,232,000 4,554,000 3,240,000 2,805,000 3,749,000 3,006,000 4,371,000 2,901,000 3,756,000 4,261,000 7,392,000 7,304,000 6,135,000 6,873,000 6,799,000 4,436,000 4,985,000 5,868,000 4,997,000 2,007,000  
        total current assets
      		134,964,000 175,860,000 237,990,000 226,474,000 241,805,000 218,009,000 205,828,000 226,470,000 244,375,000 266,310,000 284,808,000 306,794,000 330,017,000 358,182,000 378,873,000 405,106,000 439,779,000 477,172,000 505,202,000 524,093,000 755,188 
        marketable securities, non-current
      		63,023,000 52,855,000 4,691,000                   
        property and equipment
      		12,030,000 13,194,000 13,374,000 15,340,000 16,179,000 15,993,000 16,254,000 16,211,000 16,169,000 16,275,000 17,606,000 18,104,000 18,203,000 16,849,000 13,764,000 12,562,000 11,151,000 8,908,000 4,207,000 2,857,000  
        operating lease right-of-use assets
      		3,098,000 3,464,000 3,839,000 11,782,000 12,430,000 13,061,000 13,677,000 13,248,000 13,850,000 14,438,000 14,354,000 14,896,000 15,221,000 15,757,000 15,166,000 15,411,000 15,035,000 6,973,000    
        other assets
      		233,000 234,000 233,000 810,000 808,000 808,000 695,000 695,000 695,000 695,000 701,000 701,000 697,000 697,000 697,000 690,000 690,000 690,000 117,000   
        total assets
      		213,348,000 245,607,000 260,127,000 254,406,000 271,222,000 247,871,000 236,454,000 256,748,000 275,585,000 298,250,000 318,096,000 341,168,000 365,025,000 391,485,000 417,983,000 443,252,000 476,138,000 503,226,000 509,526,000 526,950,000 115,759,069 
        liabilities and stockholders’ equity
      		                     
        current liabilities:
      		                     
        accounts payable
      		1,790,000 1,623,000 1,346,000 2,234,000 1,894,000 1,931,000 2,153,000 1,379,000 1,164,000 1,766,000 2,056,000 833,000 2,657,000 3,903,000 1,775,000 2,370,000 4,293,000 3,393,000 3,172,000 3,032,000  
        accrued payroll and payroll-related costs
      		2,205,000 5,903,000 4,776,000 3,440,000 2,133,000 5,331,000 4,603,000 2,883,000 2,103,000 4,943,000            
        accrued contracted services
      		2,879,000 3,356,000 3,027,000 2,193,000 2,766,000 2,379,000 2,133,000 1,645,000 1,212,000 1,519,000            
        accrued legal settlement liability
      		 8,000,000 8,000,000 8,000,000                  
        accrued expenses and other current liabilities
      		1,557,000 1,505,000 2,096,000 3,780,000 3,840,000 4,848,000 2,839,000 3,446,000 1,883,000 1,815,000 7,428,000 7,882,000 6,033,000 10,434,000 9,586,000 7,912,000 8,779,000 7,276,000 4,024,000 3,946,000  
        warrant liabilities
      		437,000    1,594,000 4,995,000 357,000 478,000 955,000 1,274,000 1,077,000 915,000 605,000 996,000 2,118,000 2,255,000 4,592,000 7,239,000 8,176,000 15,150,000  
        current portion of operating lease liabilities
      		1,841,000 1,844,000 1,829,000 1,783,000 1,936,000 3,698,000 3,614,000 1,655,000 1,610,000 1,566,000 1,523,000           
        total current liabilities
      		10,709,000 23,025,000 22,147,000 24,019,000 12,569,000 18,187,000 15,342,000 11,008,000 7,972,000 11,609,000 11,007,000 10,193,000 10,096,000 15,706,000 12,641,000 11,432,000 14,045,000 11,528,000 7,196,000 7,864,000 1,605,439 
        operating lease liabilities
      		1,870,000 2,322,000 2,781,000 9,359,000 10,118,000 9,250,000 10,211,000 11,991,000 12,873,000 13,737,000 13,928,000 14,733,000 15,297,000 16,077,000 15,774,000 16,070,000 15,386,000 7,219,000    
        other long-term liabilities
      		25,000 34,000 40,000 45,000 21,000 19,000 24,000 11,000 14,000 11,000 19,000 32,000 24,000    240,000 206,000 239,000   
        total liabilities
      		12,604,000 25,381,000 24,968,000 33,423,000 24,302,000 32,451,000 25,934,000 23,488,000 21,814,000 26,631,000 26,031,000 25,873,000 26,022,000 32,779,000 30,533,000 29,757,000 34,263,000 26,192,000 15,611,000 23,014,000 18,675,738 
        commitments and contingencies
      		                     
        stockholders’ equity:
      		                     
        class a common stock, 0.0001 par value...
      		20,000 20,000 20,000 16,000 16,000 16,000 12,000 12,000 12,000 12,000 12,000 12,000 12,000 12,000 12,000 12,000 12,000 12,000 12,000 12,000 270 
        class b common stock, 0.0001 par value...
      		2,000 2,000 2,000 2,000 2,000 2,000 2,000 2,000 2,000 2,000 2,000 2,000 2,000 2,000 2,000 2,000 2,000 2,000 2,000 2,000 288 
        additional paid-in capital
      		920,755,000 918,190,000 915,452,000 865,671,000 862,734,000 811,998,000 773,873,000 771,460,000 768,898,000 767,239,000 765,637,000 764,139,000 762,274,000 758,366,000 753,970,000 748,302,000 744,268,000 744,252,000 731,711,000 723,641,000 18,991,736 
        accumulated other comprehensive loss
      		-382,000      153,000 -7,000 -33,000             
        accumulated deficit
      		-719,651,000 -697,980,000 -680,369,000 -644,666,000 -615,830,000 -596,641,000 -563,520,000 -538,207,000 -515,108,000 -495,634,000 -473,586,000 -448,858,000 -423,285,000 -399,674,000 -366,534,000 -334,821,000 -302,407,000 -267,232,000 -237,810,000 -219,719,000 -13,992,293 
        total stockholders’ equity
      		200,744,000 220,226,000 235,159,000 220,983,000 246,920,000 215,420,000 210,520,000 233,260,000 253,771,000 271,619,000 292,065,000 315,295,000 339,003,000 358,706,000 387,450,000 413,495,000 441,875,000 477,034,000 493,915,000  5,000,001 
        total liabilities and stockholders’ equity
      		213,348,000 245,607,000 260,127,000 254,406,000 271,222,000 247,871,000 236,454,000 256,748,000 275,585,000 298,250,000 318,096,000 341,168,000 365,025,000 391,485,000 417,983,000 443,252,000 476,138,000    115,759,069 
        warrant liabilities, current
      		 794,000 1,073,000 2,589,000                  
        warrant liabilities, non-current
      		                     
        accumulated other comprehensive income
      		 -6,000 54,000 -40,000 -2,000 45,000                
        marketable securities
      		   192,023,000 195,308,000 160,362,000 154,076,000 158,565,000 182,268,000 123,876,000 180,803,000 209,251,000 240,432,000 266,990,000 293,811,000 319,398,000 399,810,000 435,519,000 438,102,000   
        internally developed software
      		       124,000 496,000 532,000 627,000 673,000 887,000         
        stockholders’ equity
      		                     
        short-term operating lease liabilities
      		           1,478,000 1,406,000 1,369,000 1,280,000 1,150,000 973,000 859,000    
        long-term liabilities:
      		                     
        goodwill
      		              9,483,000 9,483,000 9,483,000 9,483,000    
        other assets - related party
      		                     
        liabilities, convertible preferred stock and stockholders’ equity
      		                     
        notes payable
      		                     
        convertible preferred stock
      		                     
        convertible preferred stock (series a, b, c, d, and e) 0.0001 par value with an aggregate liquidation preference of 0 and 216 as of december 31, 2021 and december 31, 2020, respectively; 0 and 92,078,549 shares authorized as of december 31, 2021 and december 31, 2020, respectively; 0 and 90,789,268 shares issued and outstanding as of december 31, 2021 and december 31, 2020, respectively
      		                     
        total liabilities, convertible preferred stock and stockholders’ equity
      		                 503,226,000 509,526,000   
        convertible preferred stock (series a, b, c, d, and e) 0.0001 par value with an aggregate liquidation preference of 0 and 216 as of september 30, 2021 and december 31, 2020, respectively; 0 and 92,078,549 shares authorized as of september 30, 2021 and december 31, 2020, respectively; 0 and 90,789,268 shares issued and outstanding as of september 30, 2021 and december 31, 2020, respectively
      		                     
        due from related parties
      		                   150,000  
        liabilities, convertible preferred stock and stockholders' equity
      		                     
        due to related parties
      		                   886,000  
        convertible preferred stock (series a, b, c, d, and e) 0.0001 par value with an aggregate liquidation preference of 0 and 216 as of june 30, 2021 and december 31, 2020, respectively; 0 and 92,078,549 shares authorized as of june 30, 2021 and december 31, 2020, respectively; 0 and 90,789,268 shares issued and outstanding as of june 30, 2021 and december 31, 2020, respectively
      		                     
        stockholders' equity
      		                     
        total stockholders' equity
      		                   503,936,000  
        total liabilities, convertible preferred stock and stockholders' equity
      		                   526,950,000  
        current assets
      		                     
        cash
      		                    591,130 
        prepaid expenses
      		                    164,058 
        cash and cash equivalents held in trust account
      		                    115,003,881 
        liabilities and shareholders’ equity
      		                     
        accounts payable and accrued expenses
      		                    1,605,439 
        warrant liability
      		                    13,045,299 
        deferred underwriting fee payable
      		                    4,025,000 
        class a common stock
      		                    92,083,330 
        preferred stock, 0.0001 par value...
      		                     
      Cashflow Statements:
      Quarterly
      Annual
        Unit: USD2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 
                           
          cash flows from operating activities:
        		                   
          net loss
        		-21,671,000 -17,611,000 -35,703,000 -28,836,000 -19,189,000 -33,121,000 -25,313,000 -23,099,000 -19,474,000 -22,048,000 -24,728,000 -25,573,000 -23,611,000 -33,140,000 -31,713,000 -32,414,000 -35,175,000 -29,422,000 -18,091,000 
          adjustments to reconcile net loss to net cash from operating activities:
        		                   
          depreciation and amortization
        		1,225,000 1,173,000 1,173,000 1,191,000 917,000 994,000 1,158,000 1,387,000 1,061,000 1,093,000 1,170,000 1,090,000 803,000      264,000 
          non-cash lease expense
        		366,000 375,000 655,000 648,000 631,000 616,000 618,000 602,000 588,000 -84,000 542,000 408,000 536,000       
          accretion on marketable securities
        		-888,000 -1,564,000 -2,195,000 -2,131,000 -2,132,000               
          loss on disposal of fixed assets
        		 0 16,000 0 15,000     144,000 0 -11,000 3,000 82,000 0     
          write-down of inventory
        		1,284,000 533,000 760,000 301,000 696,000 -5,620,000 824,000             
          change in fair value of warrant liabilities
        		-357,000 -279,000 -1,516,000 994,000 -3,401,000 4,638,000 -121,000 -477,000 -319,000 197,000 162,000 310,000 -391,000 -1,122,000 -137,000 -2,337,000 -2,647,000 -937,000 -6,975,000 
          stock-based compensation
        		2,565,000 2,688,000 2,827,000 2,896,000 2,362,000 2,405,000 2,411,000 2,426,000 1,645,000 1,602,000 1,141,000 1,865,000 3,908,000 4,107,000 4,043,000 3,770,000 -714,000   
          changes in operating assets and liabilities:
        		                   
          accounts receivable
        		358,000 48,000 162,000 115,000 301,000 -435,000 -424,000 -356,000 126,000 98,000 -139,000 -245,000 -82,000       
          legal settlement insurance receivable
        		4,638,000 0 0                 
          inventory
        		-278,000 -1,017,000 -223,000 327,000 -1,093,000 5,967,000 123,000 -1,520,000 -228,000 -771,000 -585,000 -32,000 -1,708,000       
          prepaid expenses and other current assets
        		-678,000 -1,316,000 -433,000 916,000 -730,000 1,031,000 -1,431,000 855,000 31,000 2,395,000 195,000 -1,169,000 738,000 -74,000 -2,363,000 549,000 883,000 -844,000 -2,758,000 
          accounts payable
        		316,000 145,000 -529,000 61,000 -15,000 301,000 194,000 528,000 -633,000 -488,000 1,220,000 -1,222,000 -730,000 1,165,000 -521,000 -1,404,000 1,481,000 -559,000 427,000 
          accrued expenses and other current liabilities
        		-4,053,000 788,000 494,000 847,000 -3,624,000 2,678,000 1,861,000 2,576,000 -3,094,000 821,000 403,000 1,478,000 -4,537,000 1,785,000 1,414,000 103,000 707,000 1,871,000 679,000 
          accrued legal settlement liability
        		-8,000,000 0 0                 
          operating lease liabilities
        		-455,000 -444,000 -931,000 -912,000 -894,000 -3,414,000 9,000 824,000 -820,000 -148,000 -760,000 -492,000 -743,000 392,000 125,000 684,000 8,167,000   
          other long-term liabilities
        		-10,000 -12,000 0 24,000 2,000 2,532,000 -869,000 -1,662,000 6,000 -12,000 -13,000 8,000 24,000       
          net cash from operating activities
        		-25,638,000 -16,347,000 -32,019,000 -20,197,000 -26,154,000 -22,881,000 -23,153,000 -18,553,000 -23,208,000 -20,969,000 -21,444,000 -22,925,000 -28,698,000 -19,583,000 -21,803,000 -25,945,000 -23,229,000 -17,696,000 -19,242,000 
          capital expenditures
        		-279,000 17,000 -900,000 -327,000 -1,307,000 -1,435,000 -975,000 -1,127,000 -1,046,000 367,000 -1,334,000 -969,000 -2,574,000 -3,500,000 -1,779,000 -2,962,000 -2,500,000 -3,409,000 -1,125,000 
          free cash flows
        		-25,917,000 -16,330,000 -32,919,000 -20,524,000 -27,461,000 -24,316,000 -24,128,000 -19,680,000 -24,254,000 -20,602,000 -22,778,000 -23,894,000 -31,272,000 -23,083,000 -23,582,000 -28,907,000 -25,729,000 -21,105,000 -20,367,000 
          cash flows from investing activities:
        		                   
          purchases of property and equipment
        		-279,000 17,000 -900,000 -327,000 -1,307,000 -1,435,000 -975,000 -1,127,000 -1,046,000 367,000 -1,334,000 -969,000 -2,574,000 -3,500,000 -1,779,000 -2,962,000 -2,500,000 -3,409,000 -1,125,000 
          purchases of marketable securities
        		-64,150,000 -109,371,000 -103,605,000 -71,938,000 -119,667,000 -107,390,000 -53,255,000 -129,965,000 -78,823,000     0 -733,000 701,000 -802,000 -1,806,000  
          sales and maturities of marketable securities
        		104,700,000 116,378,000 98,300,000 77,300,000 86,800,000  60,100,000             
          net cash from investing activities
        		40,271,000 7,024,000 -6,205,000 5,035,000 -34,174,000 -5,925,000 5,870,000 24,808,000 -57,428,000 61,068,000 27,122,000 29,199,000 26,039,000 25,501,000 17,169,000 72,817,000 21,698,000 -9,847,000 -439,861,000 
          cash flows from financing activities:
        		                   
          proceeds from exercise of stock options
        		 50,000 221,000 41,000 1,600,000 934,000 2,000   0    138,000 1,625,000 264,000 730,000 1,231,000 676,000 
          proceeds from issuance of common stock from direct equity offerings, net of fees and issuance costs
        		                   
          net cash from financing activities
        		 54,000 46,954,000 41,000 48,374,000 35,794,000 2,000 136,000 -56,000 -61,000    138,000 1,625,000 -584,000 730,000 1,225,000 -730,000 
          effect of exchange rate changes on cash and cash equivalents
        		-72,000 -2,000 -8,000 16,000 6,000 -15,000 -3,000 -2,000 -5,000           
          net increase in cash and cash equivalents
        		14,561,000     6,973,000 -17,284,000   40,038,000 5,888,000   6,056,000 -3,009,000   -26,318,000 -459,833,000 
          cash and cash equivalents at beginning of period
        		21,639,000 0 0 0 49,241,000 0 0 0 133,860,000 0 0 0 84,319,000 0 0 0 35,785,000 0 0 
          cash and cash equivalents at end of period
        		36,200,000 -9,271,000 8,722,000 -15,105,000 37,293,000 6,973,000 -17,284,000 6,389,000 53,163,000 40,038,000 5,888,000 6,274,000 81,660,000 6,056,000 -3,009,000 46,288,000 34,984,000 -26,318,000 -459,833,000 
          supplemental disclosure of cash flow information
        		                   
          cash paid for income taxes
        		12,000       92,000 16,000           
          supplemental disclosure of non-cash investing and financing activities
        		                   
          property and equipment purchased but not paid
        		  -365,000 412,000 28,000  217,000 49,000 231,000 243,000 -752,000         
          transfers from inventory to property and equipment
        		189,000                   
          allowance for credit losses
        		                   
          loss on lease termination
        		 0                  
          write-off of construction on process due to lease termination
        		                   
          unrealized gain on trading securities
        		                   
          realized loss on trading securities
        		                   
          change in fair value of contingent consideration
        		         0 0 -434,000 34,000 35,000 34,000 53,000 54,000   
          other
        		     -1,000 1,000 0 22,000           
          operating lease right-of-use assets
        		         0 0   -591,000 245,000 -376,000 -8,062,000   
          other assets
        		 1,000        6,000 0   0    -573,000  
          internally developed software - capitalized costs
        		     0 0 0 -59,000 0 -44,000 168,000 -887,000       
          proceeds from vesting of restricted stock
        		                   
          proceeds from issuance of common stock from direct equity offerings and the exercise of public and pre-funded warrants, net of fees and issuance costs
        		                   
          proceeds from issuance of common stock from “at-the-market” offering, net of commissions and issuance costs
        		                   
          deferred offering costs
        		      0 0 -70,000 -61,000          
          refund of issuance costs
        		                   
          write-off of construction in process due to lease termination
        		                   
          proceeds from issuance of common stock from direct equity offerings and pre-funded warrants, net of fees and issuance costs
        		                   
          net decrease in cash and cash equivalents
        		  8,722,000 -15,105,000 -11,948,000    -80,697,000    -2,659,000    -801,000   
          deferred offering costs payable
        		      0 0 75,000 -31,000          
          proceeds from issuance of common stock from direct equity offering, net of fees and issuance costs
        		   0 46,774,000               
          supplemental disclosure of cash flow information:
        		                   
          supplemental disclosure of non-cash investing and financing activities:
        		                   
          unrealized loss on trading securities
        		                   
          goodwill impairment
        		                   
          change in fair value of stock consideration
        		                   
          sales of marketable securities
        		        22,500,000 184,510,000 28,500,000 30,000,000 29,500,000 29,001,000 19,681,000 75,078,000 25,000,000   
          payment of contingent consideration - business acquisition
        		             0 0     
          payment of deferred consideration - business acquisition
        		             0 0     
          amortization on marketable securities
        		      -2,194,000 -2,204,000 -2,119,000           
          gain on disposal of fixed assets
        		                   
          refund of issuance costs from 2021 business combination
        		      0 0 14,000           
          loss on marketable securities
        		           1,181,000 -2,942,000 -2,180,000      
          other assets - related party
        		                 0 0 
          business acquisition
        		                   
          net proceeds from equity infusion from the business combination
        		                 -6,000 -1,393,000 
          payment of notes payable
        		                 0 0 
          stock issuance costs for series e convertible preferred stock
        		                 0 0 
          principal payments under finance lease obligations
        		                   
          cash received from exchange of research and development tax credits
        		                 -204,000 0 
          forgiveness of related party promissory notes
        		                 0 0 
          noncash equity issuance - business acquisition
        		                   
          noncash equity related warrants from the business combination
        		                 0 0 
          conversion of the convertible preferred stock into class a and class b common stock
        		                 0 0 
          noncash contingent consideration and holdbacks - business acquisition
        		                   
          unrealized loss on marketable securities
        		                   
          realized loss on marketable securities
        		                   
          supplemental disclosure of noncash information:
        		                   
          noncash acquisition of property and equipment
        		            847,000 462,000 152,000 -934,000 1,580,000 786,000 491,000 
          proceeds from issuance of series e convertible preferred stock
        		                   
          proceeds from issuance of notes payable
        		                   
          depreciation
        		              729,000 608,000 452,000   
          noncash equity related transaction costs from the business combination
        		                  -1,391,000 
          unrealized losses of marketable securities
        		               4,633,000 11,511,000 4,389,000  
          short-term operating lease liabilities
        		               177,000 114,000   
          stock-based compensation expense
        		                 7,078,000 7,396,000 
          write-off of intellectual property
        		                   
          principal payments under capital lease obligations
        		                  -13,000 
          due from related parties
        		                   
          due to related parties
        		                   
          redeemable class a common stock
        		                   
          numerator: earnings allocable to redeemable class a common stock
        		                   
          interest income
        		                   
          income and franchise tax
        		                   
          net earnings
        		                   
          denominator: weighted-average redeemable class a common stock
        		                   
          redeemable class a common stock, basic and diluted
        		                   
          earnings/basic and diluted redeemable class a common stock
        		                   
          non-redeemable class a and b common stock
        		                   
          numerator: net income minus redeemable net earnings
        		                   
          net income
        		                   
          redeemable net earnings
        		                   
          non-redeemable net income
        		                   
          denominator: weighted-average non-redeemable class a and b common stock
        		                   
          non-redeemable class a and b common stock, basic and diluted
        		                   
          loss/basic and diluted non-redeemable class a and b common stock